Literature DB >> 12738710

Tumors and their microenvironments: tilling the soil. Commentary re: A. M. Scott et al., A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res., 9: 1639-1647, 2003.

Jonathan D Cheng1, Louis M Weiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12738710

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  25 in total

1.  Induction of lung epithelial cell transformation and fibroblast activation by Yunnan tin mine dust and their interaction.

Authors:  Li Bian; Yong-Wen He; Rui-Zhu Tang; Li-Ju Ma; Chun-Yan Wang; Yong-Hua Ruan; Qian Gao; Ke-Wei Jin
Journal:  Med Oncol       Date:  2010-08-18       Impact factor: 3.064

2.  Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.

Authors:  Victoria J Christiansen; Kenneth W Jackson; Kyung N Lee; Patrick A McKee
Journal:  Arch Biochem Biophys       Date:  2006-11-17       Impact factor: 4.013

Review 3.  The role of the microenvironment in tumor growth and invasion.

Authors:  Yangjin Kim; Magdalena A Stolarska; Hans G Othmer
Journal:  Prog Biophys Mol Biol       Date:  2011-06-28       Impact factor: 3.667

4.  Stroma-derived three-dimensional matrices are necessary and sufficient to promote desmoplastic differentiation of normal fibroblasts.

Authors:  Michael D Amatangelo; Daniel E Bassi; Andrés J P Klein-Szanto; Edna Cukierman
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

5.  Mechanistic modeling of the effects of myoferlin on tumor cell invasion.

Authors:  Marisa C Eisenberg; Yangjin Kim; Ruth Li; William E Ackerman; Douglas A Kniss; Avner Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-30       Impact factor: 11.205

6.  Transformed epithelial cells and fibroblasts/myofibroblasts interaction in breast tumor: a mathematical model and experiments.

Authors:  Yangjin Kim; Julie Wallace; Fu Li; Michael Ostrowski; Avner Friedman
Journal:  J Math Biol       Date:  2009-11-10       Impact factor: 2.259

7.  Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-α.

Authors:  Xiao-Ping Chai; Guang-Long Sun; Yan-Fen Fang; Li-Hong Hu; Xuan Liu; Xiong-Wen Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-11-09       Impact factor: 6.150

8.  Selective fluorescence probes for dipeptidyl peptidase activity-fibroblast activation protein and dipeptidyl peptidase IV.

Authors:  Koon Siew Lai; Nan-Hui Ho; Jonathan D Cheng; Ching-Hsuan Tung
Journal:  Bioconjug Chem       Date:  2007-05-10       Impact factor: 4.774

9.  Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.

Authors:  Angela Pennisi; Xin Li; Wen Ling; Sharmin Khan; Dana Gaddy; Larry J Suva; Bart Barlogie; John D Shaughnessy; Nazneen Aziz; Shmuel Yaccoby
Journal:  Br J Haematol       Date:  2009-04-08       Impact factor: 6.998

10.  Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers.

Authors:  Pui-Chi Lo; Juan Chen; Klara Stefflova; Michael S Warren; Roya Navab; Bizhan Bandarchi; Stefanie Mullins; Ming Tsao; Jonathan D Cheng; Gang Zheng
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.